Ventyx Biosciences (VTYX) Stock Chart & Stock Price History $2.02 -0.05 (-2.27%) As of 12:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Ventyx Biosciences Stock Price Performance The Ventyx Biosciences (VTYX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 5.47%, with a year-to-date return of -7.63%. In the past month, the stock has decreased 0.83%, reflecting recent market activity. As of the latest close, Ventyx Biosciences traded at $2.07 with a market cap of $147.30 million and volume of 983,570 shares. Receive VTYX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-13.55%1 Month Performance-0.83%3 Month Performance+90.85%Year-To-Date Performance-7.63%1 Year Performance-5.47% VTYX Stock Chart for Wednesday, July, 2, 2025 VTYX Chart by TradingView Ventyx Biosciences Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$2.14$2.07-3.27%$2.20$2.06983,570 shs$147.30 million06/30/2025$2.34$2.14-8.55%$2.40$2.051.92 million shs$152.28 million06/27/2025$2.45$2.34-4.49%$2.49$2.329.45 million shs$166.51 million06/26/2025$2.40$2.45+2.08%$2.51$2.381.18 million shs$174.34 million06/25/2025$2.41$2.40-0.41%$2.48$2.241.05 million shs$170.79 million06/24/2025$2.40$2.41+0.42%$2.50$2.361.02 million shs$171.50 million06/23/2025$2.26$2.40+6.19%$2.41$2.221.26 million shs$170.78 million06/20/2025$2.37$2.26-4.64%$2.40$2.191.36 million shs$160.82 million06/19/2025$2.37$2.37$2.42$2.181.83 million shs$168.65 million06/18/2025$2.20$2.37+7.73%$2.42$2.181.83 million shs$168.65 million Get the Latest News and Ratings for VTYX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$2.54$2.20-13.39%$2.35$2.104.98 million shs$156.55 million06/16/2025$2.56$2.54-0.78%$2.63$2.49955,875 shs$180.75 million06/13/2025$2.49$2.56+2.81%$2.60$2.42844,117 shs$182.17 million06/12/2025$2.44$2.49+2.05%$2.52$2.291.57 million shs$177.19 million06/11/2025$2.65$2.44-7.92%$2.67$2.431.65 million shs$173.63 million06/10/2025$2.56$2.65+3.52%$2.75$2.552.47 million shs$188.58 million06/09/2025$2.46$2.56+4.07%$2.57$2.421.74 million shs$182.17 million06/06/2025$2.25$2.46+9.33%$2.47$2.223.52 million shs$175.06 million06/05/2025$1.99$2.25+13.07%$2.28$1.913.88 million shs$160.11 million06/04/2025$1.99$1.99$2.03$1.95646,183 shs$141.61 million06/03/2025$2.04$1.99-2.45%$2.08$1.941.62 million shs$141.61 million06/02/2025$1.68$2.04+21.79%$2.10$1.694.41 million shs$145.17 million Related Companies Day One Biopharmaceuticals Stock Chart GH Research Stock Chart Sionna Therapeutics Stock Chart Stoke Therapeutics Stock Chart ChromaDex Stock Chart Xencor Stock Chart KalVista Pharmaceuticals Stock Chart Evolus Stock Chart Sana Biotechnology Stock Chart Upstream Bio Stock Chart Receive VTYX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VTYX) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ventyx Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ventyx Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
